Related Experiment Videos
Clinical study on the tolerance of cefazedone
Arzneimittel-Forschung
|January 1, 1979
Summary
Intravenous cefazedone (Refosporen) showed good local tolerance in patients. While some experienced mild adverse effects like rash or yeast infections, significant systemic toxicity or renal impairment was not observed.
Area of Science:
- Pharmacology
- Clinical Medicine
- Infectious Diseases
Background:
- Cefazedone is a cephalosporin antibiotic.
- Intravenous administration is a common route for antibiotic delivery.
- Assessing drug tolerance is crucial for patient safety.
Purpose of the Study:
- To evaluate the tolerance of intravenous cefazedone in patients.
- To identify potential adverse effects associated with cefazedone therapy.
- To assess systemic and local tolerance of cefazedone.
Main Methods:
- Intravenous administration of cefazedone (1g or 2g, 3 times daily for 1 week) to 20 patients.
- Monitoring of various clinical and laboratory parameters.
- Assessment of local tolerance at the administration site.
Main Results:
- Good local tolerance was observed.
- Two patients discontinued treatment due to morbilliform rash (probable/possible causal relation).
- One patient developed transient thrombocytosis; two experienced yeast detection in urine.
Conclusions:
- Intravenous cefazedone demonstrated good local tolerance.
- Adverse events were generally mild and transient, with no significant impact on renal function or blood counts.
- Further investigation may be warranted for specific adverse events like rash.